EcoDrugPlus

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSNBRG00000012055
Gene Symbol: SCN8A
3 Cross references
215 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSNBRG00000022219
Gene Symbol: LOC102781573
3 Cross references
205 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSNBRG00000021905
Gene Symbol: LOC102775670
3 Cross references
207 Possible Orthologues:

Sodium- And Chloride-Dependent Glycine Transporter 1-Like

Ensembl ID : ENSNBRG00000018893
Gene Symbol: LOC102776426
3 Cross references
208 Possible Orthologues:

Sodium-Dependent Dopamine Transporter-Like

Ensembl ID : ENSNBRG00000009507
Gene Symbol: LOC102784585
3 Cross references
166 Possible Orthologues:

Sodium-Dependent Serotonin Transporter-Like

Ensembl ID : ENSNBRG00000016050
Gene Symbol: LOC102787906
3 Cross references
201 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSNBRG00000000453
Gene Symbol: LOC102788716
3 Cross references
242 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSNBRG00000000513
Gene Symbol: LOC102781846
3 Cross references
241 Possible Orthologues:

Sodium/glucose Cotransporter 2-Like

Ensembl ID : ENSNBRG00000001664
Gene Symbol: LOC102787482
3 Cross references
198 Possible Orthologues:

Sodium/hydrogen Exchanger 3-Like

Ensembl ID : ENSNBRG00000015635
Gene Symbol: LOC102791435
2 Cross references
223 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1-Like

Ensembl ID : ENSNBRG00000005085
Gene Symbol: LOC102775627
2 Cross references
198 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-3-Like

Ensembl ID : ENSNBRG00000017270
Gene Symbol: LOC102800170
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).